专业监测看板

Nalmefene vs Naloxone for the Treatment of Recurrent Respiratory Depression After Opioid Overdose

药物 / 成分：Nalmefene Injection、Naloxone Injection

登记的停止原因（原文）：No participants enrolled

Echothiophate Iodide for the Prevention of Progression of Myopia

药物 / 成分：Echothiophate Iodide 0.03% Ophthalmic Solution、Carboxymethylcellulose Sodium (0.5%)

登记的停止原因（原文）：No funding available

Evaluation of Erector Spina Plane Block(ESPB)'s Effectiveness on Patients With Lumbar Radiculopathy

药物 / 成分：Erector Spinae Plane Block、NSAID、Home Exercise Programme

登记的停止原因（原文）：Difficulties about the method of the study

Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers

药物 / 成分：Capecitabine、Docetaxel、Fluorouracil、Leucovorin

登记的停止原因（原文）：PI Decision

A Study to Evaluate the Efficacy and Safety of REL-1017 As Adjunctive Treatment of Major Depressive Disorder (MDD)

药物 / 成分：REL1017 (esmethadone HCI) (active drug)、Placebo

登记的停止原因（原文）：The study was withdrawn based on business-related matters and there are no new safety concerns related to the trial. No patients were enrolled.

Efficacy and Safety of Plasma Rich in Growth Factors (PRGF-Endoret) Eye-drops in the Treatment of Neurotrophic Keratitis

药物 / 成分：PRGF-Endoret、Artificial tears eye-drops

登记的停止原因（原文）：The study was suspended due to recruitment difficulties

Molecular Effects of Aspirin & Metformin on Colonic Epithelium

药物 / 成分：Aspirin tablet、Metformin、Aspirin and Metformin

登记的停止原因（原文）：withdrawn prior to gaining approvals

Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies

药物 / 成分：TriNav、Traditional Delivery、Doxorubicin

登记的停止原因（原文）：No participants enrolled. Inability to perform intraprocedural MRI with the intraarterial infusion catheter in place due to MRI incompatibility.

The Effect of Local Analgesia on Postoperative Gluteal Pain in Patients Undergoing Sacrospinous Ligament Fixation

药物 / 成分：marcaine and kenalog

登记的停止原因（原文）：Never received appropriate formulation.

Effect of Sevoflurane and Desflurane on Heme Oxygenase-1 Expression in Elective Cholecystectomy

药物 / 成分：Sevoflurane Group、Desflurane Group

登记的停止原因（原文）：Terminated due to lack of financial support.

Mood Disorders in Head and Neck Cancer Patients

药物 / 成分：Venlafaxine

登记的停止原因（原文）：study never opened

Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in Lymphoma

药物 / 成分：Duvortuxizumab、Ibrutinib

Study to Investigate the Food Effect and Oral Bioavailability of Tablet Formulations Relative to Suspension Formulation of JNJ-54416076 in Healthy Participants

药物 / 成分：JNJ-54416076 (Oral Suspension)、JNJ-54416076 (Formulation 1: Direct Compression Tablets)、JNJ-54416076 (Formulation 2: Fluid Bed Granulation Tablets)

登记的停止原因（原文）：JNJ-54416076 program has been stopped for strategic business reasons.

A Study of Ustekinumab in Chinese Participants With Active Systemic Lupus Erythematosus

药物 / 成分：Ustekinumab (approximately 6 mg/kg)、Ustekinumab 90 milligram (mg)、Placebo

登记的停止原因（原文）：Pre-planned IA (global study) showed lack of efficacy in this indication. No new safety signals observed, findings consistent with known profile.

A Study of Guselkumab in Adult Participants With Celiac Disease

药物 / 成分：Guselkumab、Placebo

登记的停止原因（原文）：Study terminated. Sponsor decision.

A Study of JNJ-75105186 in Healthy Japanese and Chinese Participants

药物 / 成分：JNJ-75105186、Placebo

登记的停止原因（原文）：Business Decision

A Study of JNJ-77474462 (Bermekimab) in Healthy Chinese Participants

药物 / 成分：JNJ-77474462

登记的停止原因（原文）：The development of bermekimab in Immunology is stopped

Niraparib and Dostarlimab for Patients With MMR-D/MSI-H Colorectal Cancers

药物 / 成分：Niraparib、Dostarlimab

登记的停止原因（原文）：Per drug sponsor request.

Imaging with [89Zr]Panitumumab-PET/MRI in Patients with Newly Diagnosed Colorectal Cancer

药物 / 成分：[89Zr]Panitumumab PET-MRI

登记的停止原因（原文）：Study was not able to enroll any subjects

A Phase I Study to Assess the Tolerability of 225Ac-DOTATATE in Patients With Refractory and Relapsing Multiple Myeloma Expressing Somatostatin Receptors

药物 / 成分：225Ac-DOTATATE

登记的停止原因（原文）：Sponsor decision